RESEARCH-USE BIOSIMILAR ANTIBODY
Volagidemab
Monoclonal antibody · IgG2
Volagidemab is an antagonistic glucagon receptor (GCGR) monoclonal antibody (mAb). Volagidemab can be used in the research of type 1 diabetes (T1D).
TARGETGCCR
YMonoclonal antibody
CATALOGSC-BS-038
CATALOG NUMBERSC-BS-038
MOLECULAR WEIGHTApprox. 147.02 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Volagidemab is an antagonistic glucagon receptor (GCGR) monoclonal antibody (mAb). Volagidemab can be used in the research of type 1 diabetes (T1D).
Volagidemab is a recombinant research-use antibody directed against GCCR.